
Opinion|Videos|October 19, 2026
Product Selection in Practice – Dosing, Chair Time, and Operational Burden
Justin Arnall, Breanna Taylor, and Jeff Goff break down how dosing schedules, infusion chair time, and preparation complexity factor into product selection and infusion center capacity, and how pharmacists can help institutions deliver IV iron more efficiently.
Advertisement
Justin Arnall, Breanna Taylor, and Jeff Goff break down how dosing schedules, infusion chair time, and preparation complexity factor into product selection and infusion center capacity, and how pharmacists can help institutions deliver IV iron more efficiently.
Advertisement
Related to this article

A summer PCAC vote pushes 6 peptide families toward the 503A bulks list—but the FDA's decision is still pending.

After initial breast cancer treatment, pharmacists can help patients navigate ongoing endocrine therapy, manage persistent adverse effects, and address medication concerns that affect long-term care.

Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD

The project maps how flu and HIV proteins enter cells, with the aim of developing longer-lasting vaccines.

Pharmacy teams can prevent early discontinuation by setting clear expectations for when—and how—a medication's benefit will become apparent.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
Finerenone in Heart Failure: Evidence and Practice a Year Later
3
Pelacarsen, Ziltivekimab Miss CV End Points: What to Know
4
Breast Cancer Treatment Ends, But The Medication Questions Don’t
5



